Related Content
January 16, 2019 — Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational ...
December 14, 2018 – Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As ...
December 4, 2018 — New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt ...
May 30, 2018 — Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy ...
Over the last decade, there have been considerable developments in procedural techniques and technology facilitating the ...
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously ...
September 20, 2017 — Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the ...
June 26, 2017 — Shockwave Medical recently announced two milestones for its Lithoplasty System for the treatment of ...
May 23, 2017 — Shockwave Medical announced last week CE mark for the company’s Coronary Lithoplasty System for the ...
April 12, 2017 — PinnacleHealth CardioVascular Institute last week enrolled the first patient in the United States in a ...